Castelnovo G, et al. Long-term effectiveness, safety and tolerability with fingolimod treatment in patients with multiple sclerosis in real-world treatment settings in France: final results of the VIRGILE study. Poster 1388. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024